127 related articles for article (PubMed ID: 38279484)
1. Regulatory mechanism of interaction between Y-box-binding protein 1 and heterogenous nuclear ribonucleoprotein K in cell division cycle 25a signal pathway and lung cancer metastasis.
Fu L; Yang M; Ma Y
Cell Mol Biol (Noisy-le-grand); 2023 Dec; 69(14):62-68. PubMed ID: 38279484
[TBL] [Abstract][Full Text] [Related]
2. YBX1 regulates tumor growth via CDC25a pathway in human lung adenocarcinoma.
Zhao S; Wang Y; Guo T; Yu W; Li J; Tang Z; Yu Z; Zhao L; Zhang Y; Wang Z; Wang P; Li Y; Li F; Sun Z; Xuan Y; Tang R; Deng WG; Guo W; Gu C
Oncotarget; 2016 Dec; 7(50):82139-82157. PubMed ID: 27384875
[TBL] [Abstract][Full Text] [Related]
3. Yifei Sanjie formula alleviates lung cancer progression via regulating PRMT6-YBX1-CDC25A axis.
Tang J; Yin C; Chen M; Dong M; Xu Y
Environ Toxicol; 2024 May; 39(5):3225-3237. PubMed ID: 38357781
[TBL] [Abstract][Full Text] [Related]
4. Heterogeneous nuclear ribonucleoprotein K promotes the progression of lung cancer by inhibiting the p53-dependent signaling pathway.
Li M; Yang X; Zhang G; Wang L; Zhu Z; Zhang W; Huang H; Gao R
Thorac Cancer; 2022 May; 13(9):1311-1321. PubMed ID: 35352475
[TBL] [Abstract][Full Text] [Related]
5. Regulation and related mechanism of GSN mRNA level by hnRNPK in lung adenocarcinoma cells.
Liu XH; Ma J; Feng JX; Feng Y; Zhang YF; Liu LX
Biol Chem; 2019 Jun; 400(7):951-963. PubMed ID: 30771276
[TBL] [Abstract][Full Text] [Related]
6. YAP mediates the positive regulation of hnRNPK on the lung adenocarcinoma H1299 cell growth.
Xu L; Zhang T; Huang W; Liu X; Lu J; Gao X; Zhang YF; Liu L
Acta Biochim Biophys Sin (Shanghai); 2019 Jul; 51(7):677-687. PubMed ID: 31187136
[TBL] [Abstract][Full Text] [Related]
7. Interaction of hnRNP K with MAP 1B-LC1 promotes TGF-β1-mediated epithelial to mesenchymal transition in lung cancer cells.
Li L; Yan S; Zhang H; Zhang M; Huang G; Chen M
BMC Cancer; 2019 Sep; 19(1):894. PubMed ID: 31492158
[TBL] [Abstract][Full Text] [Related]
8. Transcriptional activation of NANOG by YBX1 promotes lung cancer stem-like properties and metastasis.
Guo T; Kong J; Liu Y; Li Z; Xia J; Zhang Y; Zhao S; Li F; Li J; Gu C
Biochem Biophys Res Commun; 2017 May; 487(1):153-159. PubMed ID: 28400280
[TBL] [Abstract][Full Text] [Related]
9. Heterogeneous Nuclear Ribonucleoprotein K Is Involved in the Estrogen-Signaling Pathway in Breast Cancer.
Iwabuchi E; Miki Y; Suzuki T; Hirakawa H; Ishida T; Sasano H
Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33806648
[TBL] [Abstract][Full Text] [Related]
10. [Expression of hnRNP K in lung adenocarcinoma cells].
Tang FM; Li WM; Chen Y; Wang DM; Han J
Sichuan Da Xue Xue Bao Yi Xue Ban; 2008 Sep; 39(5):823-6. PubMed ID: 19024324
[TBL] [Abstract][Full Text] [Related]
11. The interaction of YBX1 with G3BP1 promotes renal cell carcinoma cell metastasis via YBX1/G3BP1-SPP1- NF-κB signaling axis.
Wang Y; Su J; Wang Y; Fu D; Ideozu JE; Geng H; Cui Q; Wang C; Chen R; Yu Y; Niu Y; Yue D
J Exp Clin Cancer Res; 2019 Sep; 38(1):386. PubMed ID: 31481087
[TBL] [Abstract][Full Text] [Related]
12. Selective sorting and secretion of hY4 RNA fragments into extracellular vesicles mediated by methylated YBX1 to promote lung cancer progression.
Li C; Wang W; Sun Y; Ni Y; Qin F; Li X; Wang T; Guo M; Sun G
J Exp Clin Cancer Res; 2022 Apr; 41(1):136. PubMed ID: 35410432
[TBL] [Abstract][Full Text] [Related]
13. CEBPγ facilitates lamellipodia formation and cancer cell migration through CERS6 upregulation.
Shi H; Niimi A; Takeuchi T; Shiogama K; Mizutani Y; Kajino T; Inada K; Hase T; Hatta T; Shibata H; Fukui T; Chen-Yoshikawa TF; Nagano K; Murate T; Kawamoto Y; Tomida S; Takahashi T; Suzuki M
Cancer Sci; 2021 Jul; 112(7):2770-2780. PubMed ID: 33934437
[TBL] [Abstract][Full Text] [Related]
14. LncRNA HOXC-AS3 promotes non-small-cell lung cancer growth and metastasis through upregulation of YBX1.
Su H; Fan G; Huang J; Qiu X
Cell Death Dis; 2022 Apr; 13(4):307. PubMed ID: 35387975
[TBL] [Abstract][Full Text] [Related]
15. Heterogeneous nuclear ribonucleoprotein (HnRNP) K genome-wide binding survey reveals its role in regulating 3'-end RNA processing and transcription termination at the early growth response 1 (EGR1) gene through XRN2 exonuclease.
Mikula M; Bomsztyk K; Goryca K; Chojnowski K; Ostrowski J
J Biol Chem; 2013 Aug; 288(34):24788-98. PubMed ID: 23857582
[TBL] [Abstract][Full Text] [Related]
16. C1QBP negatively regulates the activation of oncoprotein YBX1 in the renal cell carcinoma as revealed by interactomics analysis.
Wang Y; Yue D; Xiao M; Qi C; Chen Y; Sun D; Zhang N; Chen R
J Proteome Res; 2015 Feb; 14(2):804-13. PubMed ID: 25497084
[TBL] [Abstract][Full Text] [Related]
17. YBX1 regulated by Runx3-miR-148a-3p axis facilitates non-small-cell lung cancer progression.
Su H; Fan G; Huang J; Qiu X
Cell Signal; 2021 Sep; 85():110049. PubMed ID: 34082012
[TBL] [Abstract][Full Text] [Related]
18. Increased expression of the heterogeneous nuclear ribonucleoprotein K in pancreatic cancer and its association with the mutant p53.
Zhou R; Shanas R; Nelson MA; Bhattacharyya A; Shi J
Int J Cancer; 2010 Jan; 126(2):395-404. PubMed ID: 19609950
[TBL] [Abstract][Full Text] [Related]
19. [Role of heterogeneous nuclear ribonucleoprotein A2/B1 protein in the pathogenesis of non-small cell lung cancer].
Shi Y; Chen Y; Hou YY; Ji CH; Hu Q; Zhou Y; Su JA; Tan YS
Zhonghua Zhong Liu Za Zhi; 2011 Feb; 33(2):110-4. PubMed ID: 21575478
[TBL] [Abstract][Full Text] [Related]
20. YBX1/lncRNA SBF2-AS1 interaction regulates proliferation and tamoxifen sensitivity via PI3K/AKT/MTOR signaling in breast cancer cells.
Hussain SA; Venkatesh T
Mol Biol Rep; 2023 Apr; 50(4):3413-3428. PubMed ID: 36754932
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
